Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.91 USD | -1.51% | -2.15% | -12.84% |
May. 14 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
May. 10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.84% | 6.18B | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- BioInvent International To Receive $1 Million Milestone Payment in Exelixis Research Deal